Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
6.41
-0.06 (-0.93%)
At close: Sep 25, 2026
Interpace Biosciences Earnings Call Transcripts
Fiscal Year 2026
-
The meeting approved all seven proposals, including board declassification, a reverse stock split, and new equity plans. Strategic priorities include launching a new pancreatic cancer test, expanding the product portfolio, and investing in research and lab automation.